Efficacy and Safety of Omalizumab in Children (6 - < 12 Years) With Moderate-severe, Inadequately Controlled Allergic Asthma

Update Il y a 5 ans
Reference: EUCTR2015-003538-28

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

• Rate of Clinically Significant Asthma Exacerbations Per Patient in the 24-week Fixed-dose Steroid • Percentage of Participants With at Least 1 Adverse Event


Inclusion criteria

  • Moderate-severe inadequately controlled Allergic Asthma